{"id":93385,"date":"2020-12-04T13:13:00","date_gmt":"2020-12-04T13:13:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2773857"},"modified":"2020-12-04T13:13:00","modified_gmt":"2020-12-04T13:13:00","slug":"given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/","title":{"rendered":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030"},"content":{"rendered":"<p><img decoding=\"async\" width=\"235\" height=\"77\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/\">Roots Analysis<\/a> has done a detailed study on <a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\">Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking &amp; Tracing Systems, and Other Software), 2019-2030<\/a>, covering key aspects of the industry&rsquo;s evolution and identifying potential future growth opportunities.<\/p>\n<p><strong><em>To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this <\/em><\/strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\"><em>link<\/em><\/a><\/p>\n<p><strong>Key Market Insights<\/strong><\/p>\n<ul>\n<li>Presently, over 160 innovative, software-enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies<\/li>\n<li>Company involved in this domain are putting in significant efforts to develop advanced software solutions and also differentiate their offerings, from those of other industry players, in order to maintain a competitive edge<\/li>\n<li>North America is the major hub of innovation in this field, serving as the base for companies of all sizes, which are primarily engaged in developing cloud-based solutions for diverse applications<\/li>\n<li>The cell and advanced therapies market is characterized by an elaborate value chain, involving a multitude of processes and several stakeholders, each having a discrete set of priorities and requirements<\/li>\n<li>Increase in partnership activity reflects the growing interest of stakeholders in this industry; over 50% of reported deals were established to deploy software solutions for enhancing visibility and supply chain performance<\/li>\n<li>An analysis of recent activity on Twitter reveals the increasing interest and ongoing efforts of industry stakeholders in providing needle-to-needle traceability and supply chain orchestration solutions<\/li>\n<li>Given their cost saving potential across different processes and operations, we expect the cell and advanced therapy supply chain solutions market to grow at an annualized rate of around 25% over the next decade<\/li>\n<li>In the mid-long term, the projected opportunity is anticipated to be well distributed across various global regions, different end uses \/ applications and mode of deployment of various proprietary software solutions<\/li>\n<\/ul>\n<p>For more information, please visit <a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html<\/a><\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<ol>\n<li>PREFACE<\/li>\n<\/ol>\n<p>1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Scope of the Report<\/p>\n<p>1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Research Methodology<\/p>\n<p>1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Outlines<\/p>\n<ol start=\"2\">\n<li> <strong> EXECUTIVE SUMMARY<\/strong><\/li>\n<li><strong> INTRODUCTION<\/strong><\/li>\n<\/ol>\n<p>3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Context and Background<\/p>\n<p>3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An Introduction to Cell and Advanced Therapies<\/p>\n<p>3.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Classification of Advanced Therapy Medicinal Products<\/p>\n<p>3.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Market Landscape<\/p>\n<p>3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overview of Cell and Advanced Therapies Supply Chain<\/p>\n<p>3.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Donor Eligibility and Selection<\/p>\n<p>3.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sample Collection<\/p>\n<p>3.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Manufacturing<\/p>\n<p>3.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics<\/p>\n<p>3.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Verification and Treatment<\/p>\n<p>3.3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Challenges Associated with the Cell and Advanced Therapies Supply Chain<\/p>\n<p>3.3.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Process Standardization<\/p>\n<p>3.3.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Packaging and Shipping Qualification<\/p>\n<p>3.3.6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Validation of Storage Containers<\/p>\n<p>3.3.6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Process Qualification<\/p>\n<p>3.3.6.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chain of Custody Documentation<\/p>\n<p>3.3.6.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Demand Forecastin<\/p>\n<p>3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Software Solutions for Cell and Advanced Therapies Supply Chain Management<\/p>\n<p>3.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing System<\/p>\n<p>3.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management System<\/p>\n<p>3.4.3.&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management System<\/p>\n<p>3.4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management System<\/p>\n<p>3.4.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management System<\/p>\n<p>3.4.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management System<\/p>\n<p>3.4.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Electronic Clinical Outcome Assessments System<\/p>\n<p>3.4.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Orchestration Platfor<\/p>\n<p>3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Growth Drivers and Roadblocks<\/p>\n<p>3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Upcoming Trends<\/p>\n<p>3.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blockchain Technology<\/p>\n<p>3.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Internet of Things<\/p>\n<p>3.6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Augmented Reality<\/p>\n<p>3.6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Big Data Analytics<\/p>\n<p>3.6.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Artificial Intelligence<\/p>\n<ol start=\"4\">\n<li><strong> CURRENT MARKET LANDSCAPE<\/strong><\/li>\n<\/ol>\n<p>4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management: Overall Market Landscape<\/p>\n<p>4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Software Solution<\/p>\n<p>4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Key Specification and Benefits Offered<\/p>\n<p>4.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Application<\/p>\n<p>4.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Mode of Deployment<\/p>\n<p>4.2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Scale of Management<\/p>\n<p>4.2.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Regulatory Certifications \/ Accreditations<\/p>\n<p>4.2.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by End User<\/p>\n<p>4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management: Developer Landscape<\/p>\n<p>4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Year of Establishment<\/p>\n<p>4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Location of Headquarters<\/p>\n<p>4.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Company Size<\/p>\n<p>4.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Support Services Offered<\/p>\n<p>4.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leading Developers: Analysis by Number of Software Solutions<\/p>\n<ol start=\"5\">\n<li><strong> COMPANY COMPETITIVENESS ANALYSIS<\/strong><\/li>\n<\/ol>\n<p>5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methodology<\/p>\n<p>5.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Assumptions and Key Input Parameters<\/p>\n<p>5.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Competitiveness Analysis: Software Solution Providers<\/p>\n<p>5.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; COP Developers<\/p>\n<p>5.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EMS Developers<\/p>\n<p>5.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IMS Developers<\/p>\n<p>5.4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LIMS Developers<\/p>\n<p>5.4.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LMS Developers<\/p>\n<p>5.4.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PMS Developers<\/p>\n<p>5.4.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QMS Developers<\/p>\n<p>5.4.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TTS Developers<\/p>\n<ol start=\"6\">\n<li><strong> CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT: COMPANY PROFILES<\/strong><\/li>\n<\/ol>\n<p>6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brooks Life Sciences<\/p>\n<p>6.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>6.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Management Software Solution Portfolio<\/p>\n<p>6.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cryoport<\/p>\n<p>6.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>6.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>6.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Management Software Solution Portfolio<\/p>\n<p>6.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MasterControl<\/p>\n<p>6.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>6.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Management Software Solution Portfolio<\/p>\n<p>6.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>6.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SAP<\/p>\n<p>6.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>6.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Management Software Solution Portfolio<\/p>\n<p>6.5.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>6.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Savsu Technologies<\/p>\n<p>6.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>6.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>6.6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Management Software Solution Portfolio<\/p>\n<p>6.6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Development and Future Outlook<\/p>\n<p>6.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TraceLink<\/p>\n<p>6.7.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>6.7.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>6.7.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Management Software Solution Portfolio<\/p>\n<p>6.7.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<ol start=\"7\">\n<li><strong> SUPPLY CHAIN ORCHESTRATION PLATFORM: EMERGING TRENDS AND KEY Players<\/strong><\/li>\n<\/ol>\n<p>7.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>7.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Orchestration Platforms<\/p>\n<p>7.2.1.&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Key Functions of Supply Chain Orchestration Platforms<\/p>\n<p>7.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Advantages of Supply Chain Orchestration Platforms<\/p>\n<p>7.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Orchestration Platform Implementation Strategies<\/p>\n<p>7.2.3.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Building the Required Foundation<\/p>\n<p>7.2.3.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Incorporating an Appropriate Scheduling System<\/p>\n<p>7.2.3.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Integration with Core Systems \/ Processe<\/p>\n<p>7.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Orchestration Platform: Social Media Trends<\/p>\n<p>7.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Scope and Methodology<\/p>\n<p>7.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Historical Trends in Volume of Tweets<\/p>\n<p>7.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Popular Keyword<\/p>\n<p>7.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Key Industry Players<\/p>\n<p>7.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Be The Match BioTherapies&reg;<\/p>\n<p>7.4.1.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.1.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>7.4.1.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Match<\/em><\/strong><em>Source<\/em>&reg;: Software Description<\/p>\n<p>7.4.1.4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outloo<\/p>\n<p>7.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clarkston Consulting<\/p>\n<p>7.4.2.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.2.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Therapy Orchestration Platform: Software Description<\/p>\n<p>7.4.2.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outloo<\/p>\n<p>7.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Haemonetics<\/p>\n<p>7.4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>7.4.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EdgeCell&reg;: Software Description<\/p>\n<p>7.4.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertrust Patient Data Care<\/p>\n<p>7.4.4.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.4.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertrust X-Chain: Software Description<\/p>\n<p>7.4.4.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outloo<\/p>\n<p>7.4.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lykan Bioscience<\/p>\n<p>7.4.5.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.5.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unnamed Software: Software Description<\/p>\n<p>7.4.5.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MAK-SYSTEM<\/p>\n<p>7.4.6.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.6.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T.C.S.: Software Description<\/p>\n<p>7.4.6.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sedApta<\/p>\n<p>7.4.7.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.7.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; O.S.A.: Software Description<\/p>\n<p>7.4.7.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stafa Cellular Therapy<\/p>\n<p>7.4.8.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.8.2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stafa Cellular Therapy Lab: Software Description<\/p>\n<p>7.4.8.3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Title 21 Health Solutions<\/p>\n<p>7.4.9.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.9.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Therapy Software: Software Description<\/p>\n<p>7.4.9.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TrakCel<\/p>\n<p>7.4.10.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>7.4.10.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platform: Software Description<\/p>\n<p>7.4.10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<p>7.4.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vineti<\/p>\n<p>7.4.11.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Overview<\/p>\n<p>7.4.11.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Information<\/p>\n<p>7.4.11.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Personalized Therapy Management Platform: Software Description<\/p>\n<p>7.4.11.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent Developments and Future Outlook<\/p>\n<ol start=\"8\">\n<li><strong> FUNDING AND INVESTMENT ANALYSIS<\/strong><\/li>\n<\/ol>\n<p>8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Types of Funding<\/p>\n<p>8.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management: Funding and Investment Analysis<\/p>\n<p>8.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Number of Funding Instances<\/p>\n<p>8.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Amount Invested<\/p>\n<p>8.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Funding<\/p>\n<p>8.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Number of Funding Instances and Amount Invested across Different Software Solutions<\/p>\n<p>8.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Players: Analysis by Number of Funding Instances<\/p>\n<p>8.3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Investors: Analysis by Number of Funding Instances<\/p>\n<p>8.3.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Geographical Analysis by Amount Invested<\/p>\n<p>8.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concluding Remarks<\/p>\n<ol start=\"9\">\n<li><strong> PARTNERSHIPS AND COLLABORATIONS<\/strong><\/li>\n<\/ol>\n<p>9.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>9.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Partnership Models<\/p>\n<p>9.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management: Recent Collaborations and Partnerships<\/p>\n<p>9.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Year of Partnership<\/p>\n<p>9.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Partnership<\/p>\n<p>9.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Partner&rsquo;s Focus Area<\/p>\n<p>9.3.3.1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Partner&rsquo;s Focus Area<\/p>\n<p>9.3.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Platform and Partner&rsquo;s Focus Area<\/p>\n<p>9.3.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Partnership Model and Partner&rsquo;s Focus Area<\/p>\n<p>9.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Software Solution Analysis<\/p>\n<p>9.3.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Software Solutions<\/p>\n<p>9.3.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Platform and Partnership Model<\/p>\n<p>9.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Players: Analysis by Number of Partnerships<\/p>\n<p>9.3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Geographical Analysis<\/p>\n<p>9.3.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Players<\/p>\n<p>9.3.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intercontinental and Intracontinental Agreements<\/p>\n<ol start=\"10\">\n<li><strong> SUPPLY CHAIN UTILIZATION USE CASES<\/strong><\/li>\n<\/ol>\n<p>10.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management: Recent Platform Utilization Use Cases<\/p>\n<p>10.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Year of Utilization<\/p>\n<p>10.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Partner<\/p>\n<p>10.2.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Users: Distribution by Number of Platform Utilization Instances<\/p>\n<p>10.2.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Geographical Distribution of Users<\/p>\n<p>10.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Analysis by Type of Software Solution<\/p>\n<p>10.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Players: Analysis by Number of Platform Utilization Agreements<\/p>\n<p>10.2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most Active Players: Regional Analysis by Number of Platform Utilization Agreements<\/p>\n<p>10.2.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regional Distribution by Type of Software Solutions<\/p>\n<p>10.2.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intercontinental and Intracontinental Agreements<\/p>\n<ol start=\"11\">\n<li><strong> STAKEHOLDER NEEDS ANALYSIS <\/strong><\/li>\n<\/ol>\n<p>11.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>11.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management: Needs of Different Stakeholders<\/p>\n<p>11.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Comparison of Stakeholder Needs<\/p>\n<ol start=\"12\">\n<li><strong> COST SAVINGS ANALYSIS <\/strong><\/li>\n<\/ol>\n<p>12.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>12.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Key Assumptions and Methodology<\/p>\n<p>12.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cost Saving Potential of Supply Chain Management Software Solutions, 2019-2030<\/p>\n<p>12.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cost Saving Potential in Sample Collection and Processing, 2019-2030<\/p>\n<p>12.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cost Saving Potential in Manufacturing, 2019-2030<\/p>\n<p>12.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cost Saving Potential in Logistics, 2019-2030<\/p>\n<p>12.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cost Saving Potential in Patient Verification and Treatment Follow-up, 2019-2030<\/p>\n<ol start=\"13\">\n<li><strong> MARKET FORECAST<\/strong><\/li>\n<\/ol>\n<p>13.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>13.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Key Assumptions and Forecast Methodology<\/p>\n<p>13.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market, 2019-2030<\/p>\n<p>13.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Application<\/p>\n<p>13.3.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.3.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for, Manufacturing, 2019-2030<\/p>\n<p>13.3.1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for, Logistics, 2019-2030<\/p>\n<p>13.3.1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Patient Verification and Treatment Follow-up, 2019-2030<\/p>\n<p>13.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by End User<\/p>\n<p>13.3.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Biobanks, 2019-2030<\/p>\n<p>13.3.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Cell Therapy Labs \/ Commercial Organizations, 2019-2030<\/p>\n<p>13.3.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Hospitals \/ Medical Centers, 2019-2030<\/p>\n<p>13.3.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Research Institutes, 2019-2030<\/p>\n<p>13.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Type of Software Solution<\/p>\n<p>13.3.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.3.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Cell and Advanced Therapies Supply Chain Management, 2019-2030<\/p>\n<p>13.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Mode of Deployment<\/p>\n<p>13.3.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Market for Cloud-based Solutions, 2019-2030<\/p>\n<p>13.3.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Market for On-premises Solutions, 2019-2030<\/p>\n<p>13.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Scale of Operation<\/p>\n<p>13.3.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Market for Clinical Therapies, 2019-2030<\/p>\n<p>13.3.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Market for Commercial Therapies, 2019-2030<\/p>\n<p>13.3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Geography<\/p>\n<p>13.3.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market in North America, 2019-2030<\/p>\n<p>13.3.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market in Europe, 2019-2030<\/p>\n<p>13.3.6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market in Asia-Pacific, 2019-2030<\/p>\n<p>13.3.6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market in Rest of the World, 2019-2030<\/p>\n<p>13.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Overall Cell and Advanced Therapies Supply Chain Management Solutions Market: Distribution by Application, Type of Software Solution and Mode of Deployment<\/p>\n<p>13.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Sample Collection and Processing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.1.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.1.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.1.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Sample Collection and Processing, 2019-2030<\/p>\n<p>13.4.1.7.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Sample Collection and Processing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.1.7.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Sample Collection and Processing: On-premises Solutions, 2019-2030&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p>13.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.2.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.2.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Manufacturing, 2019-2030<\/p>\n<p>13.4.2.7.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Manufacturing: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.2.7.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Quality Management Systems Market for Manufacturing: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Logistics: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.3.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Logistics: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Logistics: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.3.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterprise Manufacturing Systems Market for Logistics: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.3.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Logistics: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.3.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Laboratory Information Management Systems Market for Logistics: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.3.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Logistics Management Systems Market for Logistics: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Logistics, 2019-2030<\/p>\n<p>13.4.3.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Logistics: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.3.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Logistics: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Advanced Therapies Supply Chain Management Solutions Market for Patient Verification and Treatment Follow-up, 2019-2030<\/p>\n<p>13.4.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Patient Verification and Treatment Follow-up, 2019-2030<\/p>\n<p>13.4.4.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Patient Verification and Treatment Follow-up: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.4.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell Orchestration Platforms Market for Patient Verification and Treatment Follow-up: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Patient Verification and Treatment Follow-up, 2019-2030<\/p>\n<p>13.4.4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Patient Verification and Treatment Follow-up: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Management Systems Market for Patient Verification and Treatment Follow-up: On-premises Solutions, 2019-2030<\/p>\n<p>13.4.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Patient Verification and Treatment Follow-up, 2019-2030<\/p>\n<p>13.4.4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Patient Verification and Treatment Follow-up: Cloud-based Solutions, 2019-2030<\/p>\n<p>13.4.4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Management Systems Market for Patient Verification and Treatment Follow-up: On-premises Solutions, 2019-2030<\/p>\n<ol start=\"14\">\n<li><strong> EXECUTIVE INSIGHTS<\/strong><\/li>\n<\/ol>\n<p>14.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>14.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific<\/p>\n<p>14.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Snapshot<\/p>\n<p>14.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interview Transcript: Bryan Poltilove, Former General Manager, Cell and Gene Therapy<\/p>\n<p>14.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell and Gene Therapy Catapult<\/p>\n<p>14.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Snapshot<\/p>\n<p>14.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interview Transcript: Jacqueline Barry, Chief Clinical Officer<\/p>\n<p>14.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; McKesson<\/p>\n<p>14.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Snapshot<\/p>\n<p>14.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interview Transcript: Divya Iyer, Senior Director, Corporate Strategy and Business Development, and Jill Maddux, Director, Cell and Gene Therapy Product Strategy<\/p>\n<p>14.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TrakCel<\/p>\n<p>14.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company Snapshot<\/p>\n<p>14.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interview Transcript: Martin Lamb, Former Chief Business Officer<\/p>\n<ol start=\"15\">\n<li><strong> CONCLUDING REMARKS<\/strong><\/li>\n<\/ol>\n<p>15.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chapter Overview<\/p>\n<p>15.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Key Takeaways<\/p>\n<ol start=\"17\">\n<li><strong> APPENDIX 1: <\/strong><strong>LIST OF ADDITIONAL SUPPLY CHAIN MANAGEMENT SOFTWARE SOLUTIONS<\/strong><\/li>\n<li><strong> APPENDIX 2: TABULATED DATA<\/strong><\/li>\n<li><strong> APPENDIX 3: LIST OF COMPANIES AND ORGANIZATIONS<\/strong><\/li>\n<\/ol>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/research\/\" rel=\"tag\">Research<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/biotech\/\" rel=\"tag\">biotech<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/report\/\" rel=\"tag\">report<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/pharma\/\" rel=\"tag\">pharma<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/logistics\/\" rel=\"tag\">Logistics<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/analysis\/\" rel=\"tag\">Analysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/cold-chain\/\" rel=\"tag\">Cold Chain<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/roots-analysis\/\" rel=\"tag\">Roots Analysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/cell-therapy-supply-chain\/\" rel=\"tag\">Cell Therapy Supply Chain<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/atmp\/\" rel=\"tag\">ATMP<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/market-size\/\" rel=\"tag\">market size<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/cell-therapy\/\" rel=\"tag\">Cell Therapy<\/a><\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\" target=\"_blank\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html<\/a><br \/><b>Contact Information:<\/b><br \/>Contact:<br \/>\nGaurav Chaudhary<br \/>\ngaurav.chaudhary@rootsanalysis.com<\/p>\n<p>Roots Analysis<br \/>\nA430, 4th Floor,<br \/>\nBestech Business Towers, Sector 66, Mohali, India<br \/>\nsales@rootsanalysis.com<br \/>\n+1 (415) 800 3415<br \/>\n+44 (122) 391 1091<br \/>\nWeb: https:\/\/www.rootsanalysis.com\/<br \/>\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/>\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/wire\/\" rel=\"category tag\">Wire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Contact:<br \/>\nGaurav Chaudhary<br \/>\ngaurav.chaudhary@rootsanalysis.com<\/p>\n<p>Roots Analysis<br \/>\nA430, 4th Floor,<br \/>\nBestech Business Towers, Sector 66, Mohali, India<br \/>\nsales@rootsanalysis.com<br \/>\n+1 (415) 800 3415<br \/>\n+44 (122) 391 1091<br \/>\nWeb: https:\/\/www.rootsanalysis.com\/<br \/>\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/>\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"235\" height=\"77\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png\" alt=\"\">Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking &amp; Tracing Systems, and Other Software), 2019-2030, covering key aspects of the &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-203\/\">Continue reading <span>Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":248,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,5,67,57,64,4,54],"tags":[],"class_list":["post-93385","post","type-post","status-publish","format-standard","hentry","category-english","category-extended-distribution","category-icn-internal-distribution","category-ips","category-reportedtimes","category-research-newswire","category-wire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business\" \/>\n<meta property=\"og:description\" content=\"Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking &amp; Tracing Systems, and Other Software), 2019-2030, covering key aspects of the &hellip; Continue reading Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-04T13:13:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png\" \/>\n<meta name=\"author\" content=\"roots.analysis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"roots.analysis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"33 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\",\"name\":\"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png\",\"datePublished\":\"2020-12-04T13:13:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451\",\"name\":\"roots.analysis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g\",\"caption\":\"roots.analysis\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/roots-analysis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/","og_locale":"en_US","og_type":"article","og_title":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business","og_description":"Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking &amp; Tracing Systems, and Other Software), 2019-2030, covering key aspects of the &hellip; Continue reading Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/","og_site_name":"Business","article_published_time":"2020-12-04T13:13:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png","type":"","width":"","height":""}],"author":"roots.analysis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"roots.analysis","Est. reading time":"33 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/","url":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/","name":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png","datePublished":"2020-12-04T13:13:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/12\/4671-1607061621.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2020\/12\/04\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451","name":"roots.analysis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g","caption":"roots.analysis"},"sameAs":["https:\/\/icrowdnewswire.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/roots-analysis\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/93385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/248"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=93385"}],"version-history":[{"count":3,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/93385\/revisions"}],"predecessor-version":[{"id":93568,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/93385\/revisions\/93568"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=93385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=93385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=93385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}